Cover Image

Prognostic significance of neutrophil to lymphocyte ratio in patients with metastatic breast cancer on the background of eribulin therapy

Background. The neutrophil to lymphocyte ratio (NLR) is a prognostic marker in various carcinomas, including breast cancer. The NLR reflects the balance of systemic immunity and is associated with survival in patients with solid tumors.Aim. This study retrospectively evaluated the significance of th...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Zyuzyukina (Author), V. A. Komissarova (Author), N. O. Popova (Author), V. E. Goldberg (Author), R. A. Zukov (Author)
Format:	Book
Published:	ABV-press, 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Breast cancer prognostication with neutrophil-lymphocyte ratio and platelet-lymphocyte ratio
by: Taha Bahgat
Published: (2017)

Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study
by: L. A. Tashireva, et al.
Published: (2022)

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study
by: Xuan Liu, et al.
Published: (2016)

Budget impact of eribulin in metastatic breast cancer in Russian Federation
by: S. K. Zyryanov, et al.
Published: (2018)

Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?
by: Tural Onur S, et al.
Published: (2016)

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy
by: Doherty MK, et al.
Published: (2015)

Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study
by: Sümeyre Seda Ertekin, et al.
Published: (2024)

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
by: Doherty MK, et al.
Published: (2015)

Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma
by: Wael Abdo Hassan, et al.
Published: (2023)

Prognostic value of rise in neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting the mortality in pediatric intensive care
by: Siby Mathews, et al.
Published: (2018)

Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Pediatric Parotid Cancer
by: Dongjie Seng, et al.
Published: (2019)

Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy
by: Jon Røikjær Henriksen, et al.
Published: (2020)

The Significance of Neutrophil-Lymphocyte Ratio and Mean Corpuscular Volume in Diagnosis of Preeclampsia
by: Çağlar Yıldız, et al.
Published: (2016)

Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies
by: Sabrina Rossi, et al.
Published: (2017)

Prognostic Relevance of Pretreatment Peripheral Neutrophil Count and Neutrophil-to-lymphocyte Ratio in Primary Cutaneous Angiosarcoma
by: Kentaro Awaji, et al.
Published: (2021)

Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea
by: Tremblay G, et al.
Published: (2016)

Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer
by: Hayriye Şahinli, et al.
Published: (2019)

Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio in Missed Abortion
by: Ismail Biyik, et al.
Published: (2020)

Mutations of the PIK3CA gene in patients with breast cancer in the Krasnoyarsk region
by: A. V. Zyuzyukina, et al.
Published: (2024)

Clinical significance of neutrophils-to-lymphocytes ratio in renal injury of primary Sjögren's syndrome
by: Hao-shuang Chen, et al.
Published: (2023)

Neutrophil to Lymphocyte Ratio in Preeclampsia
by: Alfian Prasetyo, et al.
Published: (2021)

Diagnostic, prognostic, and predictive importance of neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and CA125 in endometrial hyperplasia and carcinoma
by: Bharti Kumari, et al.
Published: (2024)

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma
by: Tan Xie, et al.
Published: (2023)

High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors
by: Corinne A. Calo, et al.
Published: (2022)

Neutrophil-to-lymphocyte ratio used as prognostic factor marker for dilated cardiomyopathy in childhood and adolescence
by: Fátima Derlene da Rocha Araújo, et al.
Published: (2019)

Diagnostic significance of neutrophil to lymphocyte ratio in endometriosis: a systematic review and meta-analysis
by: Fatemeh Tabatabaei, et al.
Published: (2023)

Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio in Mucoepidermoid Carcinoma of Pediatrics: A Multicenter Study
by: Hua Gao, et al.
Published: (2020)

Correlation of serum NFкB levels with neutrophil-lymphocyte ratio and platelet -lymphocyte ratio in breast cancer patients
by: Desy Thayyil Menambath, et al.
Published: (2024)

Neutrophil-lymphocyte and Platelet-lymphocyte Ratios in Febrile Seizures
by: Sonay İncesoy Özdemir, et al.
Published: (2022)

Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic plaque psoriasis
by: Sudeshna Mondal, et al.
Published: (2022)

Increased Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Chronic and Severe Urticaria
by: Sarah Weissmann, et al.
Published: (2024)

Predictive role of platelets to lymphocytes ratio and neutrophil to lymphocytes ratio in COPD exacerbation
by: Hussien Fayiad, et al.
Published: (2024)

The Correlation Between Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with Hepatic Echinococcosis
by: E Weijian, et al.
Published: (2021)

Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) – Risk of Death Inflammatory Biomarkers in Patients with COVID-19
by: Dymicka-Piekarska V, et al.
Published: (2023)

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
by: M. Liontos, et al.
Published: (2021)

Prognostic Value of Neutrophil to Lymphocyte Ratio on Pathologic Findings of Transrectal Ultrasonography Guided Biopsy of Prostate
by: Iraj Khosrovpanah, et al.
Published: (2018)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Nondialysis Chronic Kidney Patients
by: Gysllene M. C. Brito, et al.
Published: (2021)

The Relationship Between the Neutrophil to Lymphocyte Ratio, The Platelet to Lymphocyte Ratio, and Cardiac Syndrome X
by: Cao GY, et al.
Published: (2022)

Predictive value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in decompensated heart failure
by: Mahmoud Ashry, et al.
Published: (2019)

NEUTROPHIL-TO-LYMPHOCYTE RATIO, LYMPHOCYTE-TO-MONOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO CORRELATES WITH HISTOPATHOLOGICAL GRADING OF ORAL SQUAMOUS CELL CARCINOMA
by: Mihnea Octavian Petrescu, et al.
Published: (2020)